secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNBX Pharmaceuticals Inc. (CNBX)
CIK:        0001343009
Form:       8-K
Filed at:   2024-03-22T23:59:59+00:00
Accession:  0001683168-24-001610
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNBX Pharmaceuticals replaces independent auditor with no disagreements
-----------------------------------------------------------------------

- Replaced Weinstein International CPA with Elkana Amitai, CPA effective March 18, 2024.
- Auditor change covers fiscal year ended August 31, 2023 and subsequent periods.
- No disagreements or reportable events occurred with former auditor during prior fiscal years.
- Former accountant's letter attached as Exhibit 16.1; Board approved change on March 18, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1343009/000168316824001610/0001683168-24-001610-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1343009/000168316824001610/cnbx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-001610

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer